Eveline Barbieri, M.D., Ph.D.
Picture
Eveline Barbieri, M.D., Ph.D.
Assistant Professor
Positions
- Assistant Professor
-
Pediatrics
Hematology/Oncology
Baylor College of Medicine
Houston, TX US
- Instructor
-
Pediatrics
Hematology/Oncology
Baylor College of Medicine
Houston, Texas United States
- Research Post-Doctoral Associate and PhD student
-
Pediatrics
Hematology/Oncology
Baylor College of Medicine
Houston, Texas United States
Education
- PhD from University of Bologna
- 04/2010 - Bologna, Italy
- Oncology and Experimental Pathology
- MD from University of Bologna
- 09/2005 - Bologna, Italy
- Pediatrics- Hematology Oncology
- MD from University of Bologna
- 03/1999 - Bologna, Italy
Professional Interests
- Neuroblastoma
- Metabolism and Cancer
- Developmental Therapeutics
Websites
Selected Publications
- "p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy." :
- "Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma." :
- "A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma.." :
- "Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma." :
- Chen Z, Lin Y, Barbieri E, Burlingame S, Hicks J, Ludwig A, Shohet JM "Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.." Neoplasia. 2009 August ; 11 (8): 753-62. Pubmed PMID: 19649205
- Barbieri E, Mehta P, Chen Z, Zhang L, Slack A, Berg S, Shohet JM "MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death.." Mol. Cancer Ther.. 2006 September ; 5 (9): 2358-65. Pubmed PMID: 16985070
Memberships
- AACR
- ASPHO
- AIEOP
Funding
- Novel differentiating therapies for high-risk neuroblastoma
- $345,000.00 (07/01/2014 - 06/30/2019) Grant funding from St Baldrick's Scholars
Languages
Italian
Log In to edit your profile
